Skip to product information
1 of 1

Elabscience

SKU:E-AB-13070

SNCA Polyclonal Antibody

SNCA Polyclonal Antibody

Regular price $420.00 USD
Regular price Sale price $420.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

SNCA Polyclonal Antibody

The SNCA Polyclonal Antibody is a highly reliable and efficient tool designed for the detection and analysis of SNCA protein expression. This antibody is produced using advanced techniques, ensuring its high specificity and sensitivity. It has been extensively validated for various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The SNCA Polyclonal Antibody exhibits exceptional performance in detecting SNCA protein in a wide range of samples, including human, mouse, and rat tissues. Its superior affinity and selectivity enable accurate and precise quantification of SNCA expression levels. This antibody is an invaluable asset for researchers studying neurodegenerative diseases, as SNCA is a key protein associated with Parkinson's disease and other related disorders.

With its robust and reproducible results, the SNCA Polyclonal Antibody offers researchers a reliable tool for investigating the role of SNCA in disease progression and therapeutic interventions. Its exceptional performance characteristics, combined with its ease of use, make it an ideal choice for both experienced scientists and newcomers in the field.

The SNCA Polyclonal Antibody is supplied in a convenient format, ensuring ease of storage and handling. It is provided in a liquid form, ready for immediate use, eliminating the need for time-consuming reconstitution. Each batch of this antibody undergoes rigorous quality control procedures to guarantee consistent performance and reliability.

In summary, the SNCA Polyclonal Antibody is a highly specific and sensitive tool that enables accurate detection and analysis of SNCA protein expression. Its exceptional performance characteristics, combined with its ease of use, make it an indispensable asset for researchers in the field of neurodegenerative diseases.

View full details